News
Hyderabad Startup Explores AI Driven Therapeutics
10+ min ago (470+ words) urbanacres. in Hyderabad Startup Explores AI Driven Therapeutics A Hyderabad-based biotechnology startup is advancing the use of artificial intelligence and nanotechnology in drug development, highlighting the city's growing role in healthcare innovation and life sciences research. The development reflects a…...
Anthropic's Claude Science Moves the AI Company Into Drug Discovery " and Rewrites the Model Company Playbook
29+ min ago (543+ words) Anthropic is no longer just selling AI to drug developers " it's becoming one, and that vertical move changes the competitive logic of the entire AI-for-science stack. Anthropic Claude Science " Signal Snapshot Announced products: Claude Science workbench + internal drug discovery program…...
Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention
7+ hour, 54+ min ago (78+ words) As of the date of this press release, Botreso" and PCP remain investigational new drug candidates and have not been approved for commercial use in any jurisdiction. Jyong Biotech will comply with applicable regulatory disclosure obligations and provide timely, accurate,…...
Using Organ-On-A-Chip Technology To Unlock Patient-Derived Precision Medicine
8+ hour, 17+ min ago (154+ words) Bioprocess Online Using Organ-On-A-Chip Technology To Unlock Patient-Derived Precision Medicine Personalized medicine promises treatments tailored to how each patient's biology responds, but real-world decision-making still leans heavily on limited biomarkers and simplified lab models. These approaches often miss the dynamic…...
Brazil Invests $12 Million in Biodiversity to Develop Drug Molecules, but When Will It Reduce Dependence on Imported Pharmaceutical Ingredients?
13+ hour, 8+ min ago (697+ words) Brazil launched, this Friday, July 3, a new research center dedicated to the development of Active Pharmaceutical Ingredients, known as APIs, from the Brazilian biodiversity. The initiative brings together Embrapii, CNPEM, and Ministry of Health, with an investment of R$ 60 million…...
IMU, Waters Partner To Advance AI Immune Profiling
7+ hour, 52+ min ago (498+ words) Technology Networks...
Anthropic plans to create its own drugs
12+ hour, 21+ min ago (173+ words) Anthropic has decided to develop its own drugs. Head of Life Sciences Eric Kauderer-Abrams said the company will focus on finding treatments for "neglected" diseases. AI companies have long sought to win over customers from the scientific and pharmaceutical sectors:…...
Vascular organoid patches offer new hope for coronary artery disease treatment
18+ hour, 57+ min ago (173+ words) image: Immunofluorescence staining of the ischemic border zone showing "SMA" (green) / HNA" (cyan) double-positive cells, indicating engraftment of transplanted human smooth muscle cells into the porcine myocardium. Nuclei are counterstained with DAPI (blue). view more Yasuhiro Shudo and his team…...
Insilico Medicine and Takeda collaborate on drug discovery
13+ hour, 12+ min ago (18+ words) Bio World News Insilico Medicine and Takeda collaborate on drug discovery...
Anthropic Plans to Develop Its Own Drugs
12+ hour, 26+ min ago (945+ words) Anthropic just announced something that goes way beyond chatbots and coding tools. At an event called "The Briefing: AI for Science," the company unveiled Claude Science, a workbench that pulls scattered research tools and data into one place and helps…...